Laden…
Evidence-based risk assessment and known adverse effects
Risk Classification: Moderate Risk
3,4-CTMP carries a moderate risk profile. Acute and chronic risks depend significantly on dose, frequency, route of administration, and individual predispositions.
Risk data is being compiled
Detailed risk information for 3,4-CTMP is not yet available in English. In the meantime, consult peer-reviewed sources or PsychonautWiki.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.